FDA Inspection
Charles River Laboratories, Inc. DBA Charles River, EndosafeCharles River Laboratories, Inc. DBA Charles River, Endosafe – FDA Inspection, May 17, 2019
Record Details
This FDA Inspection record concerns Charles River Laboratories, Inc. DBA Charles River, Endosafe, with an inspection on May 17, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- May 17, 2019
- Product Type
- Biologics
View Company Profile
ID · fb32a587-3daf-412b-9719-e04dc7558cc5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1091172
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of Charles River Laboratories, Inc. DBA Charles River, Endosafe
6| Date | Classification | Office | Project area |
|---|---|---|---|
| March 27, 2026 | Not classified | Atlanta District Office | Drug Quality Assurance |
| August 20, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 13, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 24, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 15, 2013 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Charles River Laboratories, Inc. DBA Charles River, Endosafe
- FDA Inspection 1309514 - 2026-03-27
- FDA Inspection 1120385 - 2019-08-20
- FDA Inspection 961187 - 2016-01-13
- FDA Inspection 876149 - 2014-04-24
- FDA Inspection 819221 - 2013-01-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.